[What is the future for niacin after the AIM-HIGH study?]

Kardiol Pol. 2012;70(3):315-6.
[Article in Polish]
No abstract available

MeSH terms

  • Cardiovascular Diseases / prevention & control*
  • Cholesterol, HDL / drug effects*
  • Cholesterol, LDL / drug effects*
  • Humans
  • Hypolipidemic Agents / therapeutic use*
  • Metabolic Syndrome / drug therapy*
  • Niacin / therapeutic use*
  • Randomized Controlled Trials as Topic

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Hypolipidemic Agents
  • Niacin